Evidence map›Paper›PMID 33705228›Full record

ArticleThe Journal of urology2021

Reply by Authors.

Nitin K Yerram, Lori Long, Luke P O'Connor, Alex Z Wang, Michael Ahdoot, Amir H Lebastchi, Sandeep Gurram, Johnathan Zeng, Heather Chalfin, Stephanie A Harmon and 8 more

Abstract readComment
PubMed Publisher
In one paragraph

Article in The Journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Nitin K YerramUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Lori LongCenter for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Luke P O'ConnorUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Alex Z WangUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Michael AhdootUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Amir H LebastchiUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Sandeep GurramUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Johnathan ZengDivision of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Heather ChalfinUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Stephanie A HarmonClinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, Maryland.
Sherif MehralivandMolecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Maria J MerinoLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Howard L ParnesLaboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Peter L ChoykeMolecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Joanna ShihDivision of Cancer Prevention, National Cancer Institutes, National Institutes of Health, Bethesda, Maryland.
Bradford J WoodCenter for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Baris TurkbeyMolecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Peter A PintoUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Funding

Prostate Cancer ImagingZIABC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$49.2M
Prostate SectionZIABC011081 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PINTO, PETER · 2009 to 2025
$15.2M
Imaging, image guided biopsy and treatment of prostate cancerZIABC012062 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TÜRKBEY, BARIS · 2021 to 2025
$1.3M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33705228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.